Akari Therapeutics (NASDAQ:AKTX)

Akari Therapeutics (NASDAQ:AKTX)


Share Price
$ 2.03
Change
0.11 (5.73 %)
Market Cap
$33.51 m
Proactive Investors - Run By Investors For Investors

Akari Therapeutics

We are developing life-transforming treatments for autoinflammatory diseases involving the complement (C5) and leukotriene (LTB4) pathways.

EPIC: AKTX
Market: NASDAQ:AKTX
52-week High/Low: $9.19 / $1.56
Sector: Pharmaceuticals [T3]
Market Cap: $33.51 m
Website: www.akaritx.com
col 3
col 4
col 5
col 6

Akari Therapeutics Timeline

Video RSS

Videos

VIEW ALL VIDEOS
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use